Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Merck
Company Monitoring Page for Merck
latest headlines for company on cafepharma
Merck Takes on Gilead With Sharply Lower Hepatitis C Drug Price
TheStreet.com
Fri, 01/29/16 - 10:34 am
Tags:
Merck
,
Gilead Sciences
,
hepatitis C
,
Zepatier
,
drug pricing
Merck bets up to $515M on an epigenetic project for cancer and blood disease
Fierce Biotech
Thu, 01/28/16 - 09:11 pm
Tags:
Merck
,
epigenetics
,
CRUK
,
blood disease
,
cancer
,
R&D
US Big Pharma: What To Watch For In Q4 Results
Yahoo/Benzinga
Mon, 01/25/16 - 10:20 pm
Tags:
earnings
,
Eli Lilly
,
JNJ
,
Bristol-Myers Squibb
,
AbbVie
,
Pfizer
,
Merck
Merck teams with Affimed on immuno-oncology combo
Fierce Biotech
Mon, 01/25/16 - 10:01 pm
Tags:
Merck
,
Affimed
,
immuno-oncology
Dozens of drug makers agree on effort to combat antibiotic resistance
Stat
Wed, 01/20/16 - 09:36 pm
Tags:
antibiotic resistance
,
Merck
,
Pfizer
,
Sanofi
,
JNJ
,
Roche
,
Novartis
,
AstraZeneca
How Will Merck (MRK) Stock Be Affected by Ebola Vaccine?
TheStreet.com
Wed, 01/20/16 - 10:09 am
Tags:
Merck
,
ebola virus
,
vaccines
,
GAVI
Patent Expirations Of Crestor And Zetia And The Impact On Other Cholesterol Drugs
Forbes
Mon, 01/18/16 - 08:26 pm
Tags:
patents
,
Crestor
,
Zetia
,
AstraZeneca
,
Merck
It's Merck vs. Merck as name confusion, complicated by social media, leads to legal showdown
Fierce Pharma
Sat, 01/16/16 - 11:39 am
Tags:
Merck
,
Merck KGaA
,
social media
Merck to pay $830 million to settle lingering suit over Vioxx statements
Marketwatch
Fri, 01/15/16 - 07:28 am
Tags:
Merck
,
Vioxx
3 Things You Absolutely Must Know About Merck
Motley Fool
Tue, 01/12/16 - 02:30 pm
Tags:
Merck
,
M&A
,
Keytruda
,
elbasvir/grazoprevir
,
Kenneth Frazier
Analyzing Keytruda: Why Is It Important for Merck?
Yahoo/Market Realist
Mon, 01/11/16 - 06:35 pm
Tags:
Keytruda
,
Merck
Merck’s 4Q15 Earnings: Expected Growth Contributors
Yahoo/Market Realist
Fri, 01/8/16 - 09:50 am
Tags:
Merck
,
earnings
3 Potential Blockbuster Drugs Launching in 2016
Investors.com
Wed, 01/6/16 - 10:57 am
Tags:
Merck
,
hepatitis C
,
elbasvir/grazoprevir
,
Gilead Sciences
,
sofosbuvir/velpatasvir
,
Eli Lilly
,
psoriasis
,
ixekizumab
Merck CEO: Eager for deals, strong prospects for new drugs
Yahoo/AP
Tue, 01/5/16 - 03:14 pm
Tags:
Merck
,
Kenneth Frazier
,
Pharma CEOs
Is AstraZeneca a Better Suitor for Relypsa Than Sanofi?
Bidness, ETC
Mon, 12/28/15 - 10:03 am
Tags:
AstraZeneca
,
Relypsa
,
Sanofi
,
Merck
,
M&A
This Is the Most Effective Way to Treat Lung Cancer, Study Shows
Motley Fool
Mon, 12/28/15 - 09:49 am
Tags:
lung cancer
,
Galena Biopharma
,
Inovio
,
Merck
,
Bristol-Myers Squibb
10 Big Idea Biotech Startups From 2015
Forbes
Sat, 12/26/15 - 10:58 am
Tags:
biotech
,
Merck
,
Moderna Therapeutics
,
GSK
,
Spero
,
Biogen
,
Neon Therapeutics
,
RaNA
The Best Merck & Co. Inc. Headlines in 2015
Motley Fool
Thu, 12/24/15 - 10:18 am
Tags:
Merck
,
Keytruda
,
Jimmy Carter
,
hepatitis C
,
grazoprevir/elbagavir
Relypsa Gets More Attractive For Merck, Sanofi
Bidness, ETC
Wed, 12/23/15 - 09:26 pm
Tags:
Relypsa
,
Merck
,
Sanofi
,
M&A
Is Merck & Co. About to Derail Gilead Sciences?
Motley Fool
Tue, 12/22/15 - 09:59 pm
Tags:
Merck
,
Gilead Sciences
,
grazoprevir/elbasvir
,
Viekira Pak
,
AbbVie
Pages
« first
‹ previous
…
88
89
90
91
92
93
94
95
96
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.